SCHEMBL5162199

SCHEMBL5162199

Cc1ccc(NC(=O)c2ccc(CCN3CCN(C)CC3)cc2)cc1Cc1nc(-c2cccnc2)cs1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 17/20 0.64
BCR P11274 16/20 0.64
LYN P07948 5/20 0.64
PDGFRA P16234 4/20 0.64
KIT P10721 4/20 0.64
LCK P06239 4/20 0.64
CSF1R P07333 4/20 0.64
PDGFRB P09619 3/20 0.64
SRC P12931 3/20 0.64
EGFR P00533 3/20 0.64
ERBB2 P04626 2/20 0.64
FYN P06241 2/20 0.64
FGR P09769 2/20 0.64
BRAF P15056 2/20 0.64
NQO2 P16083 2/20 0.64
EPHA8 P29322 2/20 0.64
ABL2 P42684 2/20 0.64
FRK P42685 2/20 0.64
BLK P51451 2/20 0.64
DDR1 Q08345 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14789747 0.93 ABL1 (0.74) ABL1BCRLYNPDGFRAKIT
SCHEMBL718122 0.89 ABL1 (0.58) ABL1BCRLYNPDGFRAKIT
SCHEMBL716920 0.86 ABL1 (0.67) ABL1BCRLYNPDGFRAKIT
SCHEMBL5503213 0.86 ABL1 (0.51) ABL1BCRLYNPDGFRAKIT
SCHEMBL717185 0.86 ABL1 (0.56) ABL1BCRLYNPDGFRAKIT
SCHEMBL717868 0.84 KIT (0.69) ABL1BCRLYNKITCSF1R
SCHEMBL716307 0.84 KDM4E (0.52) ABL1BCRLYNPDGFRAKIT
SCHEMBL5971854 0.82 ABL1 (0.80) ABL1BCRLYNPDGFRAKIT
SCHEMBL5174867 0.82 CSF1R (0.52) ABL1BCRLYNPDGFRAKIT
SCHEMBL718546 0.80 ABL1 (0.49) ABL1BCRLYNPDGFRAKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1758654-A1 USE OF C-KIT INHIBITORS FOR TREATING PLASMODIUM RELATED DISEASES AB Science (FR) 2007-03-07 EP disclosed
EP-1746990-A1 USE OF MAST CELLS INHIBITORS FOR TREATING PATIENTS EXPOSED TO CHEMICAL OR BIOLOGICAL WEAPONS AB Science (FR) 2007-01-31 EP disclosed
EP-1624873-A2 USE OF TYROSINE KINASE INHIBITORS FOR TREATING CEREBRAL ISCHEMIA AB Science (FR) 2006-02-15 EP disclosed
WO-2005115304-A2 USE OF C-KIT INHIBITORS FOR TREATING FIBRODYSPLASIA AB SCIENCE (FR) 2005-12-08 WO disclosed
WO-2005112920-A1 USE OF MAST CELLS INHIBITORS FOR TREATING PATIENTS EXPOSED TO CHEMICAL OR BIOLOGICAL WEAPONS AB SCIENCE (FR) 2005-12-01 WO disclosed
WO-2005102455-A1 USE OF C-KIT INHIBITORS FOR TREATING PLASMODIUM RELATED DISEASES AB SCIENCE (FR) 2005-11-03 WO disclosed
EP-1525200-A1 2-(3-AMINOARYL)AMINO-4-ARYL-THIAZOLES AND THEIR USE AS C-KIT INHIBITORS AB Science (FR) 2005-04-27 EP disclosed
WO-2004096225-A2 USE OF TYROSINE KINASE INHIBITORS FOR TREATING CEREBRAL ISCHEMIA AB SCIENCE (FR) 2004-11-11 WO disclosed
WO-2004014903-A1 2-(3-AMINOARYL)AMINO-4-ARYL-THIAZOLES AND THEIR USE AS C-KIT INHIBITORS AB SCIENCE (FR) 2004-02-19 WO disclosed